Medical Device News Magazine

Toyochem Co Launches High Moisture-permeable Acrylic Adhesives for Healthcare Field

About Medical Device News Magazine

About Medical Device News Magazine. We are a digital publication founded in 2008 located in the United States.

Advertise with Medical Device News Magazine! Join Our #1 Family of Advertisers!

We pride ourselves on being the best-kept secret when it comes to distributing your news! Our unique digital approach enables us to circulate your...

February 15, 2021

Toyochem Co., Ltd., the polymers and coatings arm of Japan’s Toyo Ink Group, has launched a new healthcare-use line of pressure-sensitive adhesives (PSAs) under its Oribain™ brand of acrylic adhesive solutions.

Toyochem notes the new PSA system addresses the demand for medical tapes and surgical dressing materials that offer high moisture absorbency and breathability, thus minimizing skin maceration and infection. Moreover, the adhesive compositions are based on acrylics – not silicones – so they do contain any substances that may contaminate coating environments or cause costly bonding issues.

Conventional pressure-sensitive acrylic adhesives commonly used in modern medical tapes tend to exhibit low moisture permeability and to easily trap heat and water vapors released from the skin. This often leads to skin irritation, skin maceration, rashes and even bacterial growth. To address this issue, Toyochem researchers applied its advanced resin synthesis technology to form a polymeric composition that substantially raises the moisture permeability rate of the adhesive layer.

Early evaluation testing by our end customers has produced promising results,” said Nao Nakamura, general manager of Toyochem’s adhesives division. “The new Oribain PSA has consistently reached water vapor transmission rates of 2,000g/m2/24 hours. These values are considerably higher than those of traditional acrylic adhesives, which typically range from 500 to 1,000g/m2/24 hours. We were able to do so, all the while maintaining mechanical performance requirements for adhesion and peel strength.”
Moreover, Oribain PSA systems are acrylic-based and do not contain silicones, which are widely used in today’s medical tape adhesives. Thus, the new PSA compositions do not contain any substances that may contaminate coatings lines or processing environments, for a more user- and cost-friendly alternative to silicone types.

In addition to Oribain acrylic PSAs, Toyochem’s comprehensive portfolio includes the Cyabine™ brand of polyurethane PSA solutions, including high moisture-permeability systems. PSA compositions can be customized to meet ISO-10993-1 or other FDA-recognized biocompatibility standards.

Toyochem has been delivering highly reliable adhesive systems for decades, ranking as the #1 manufacturer of sports tape adhesives in China. Production and development centers in both Japan and China have boosted the company’s capability to customize and expand its product offerings to meet the stringent performance demands of the healthcare, packaging and various industrial markets. In line with its growth strategy, Toyochem is now looking to strengthen its presence in the global medical adhesives market, in particular for such applications as dressing and surgical tapes.

 

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Other News

Shoulder Innovations Further Strengthens IP Portfolio in Key Areas with Recent Patent Grants

"These recent grants further strengthen key patent families that are foundational to our technology, and we are pleased the USPTO continues to recognize our meaningful innovation in the shoulder arthroplasty segment," said Rob Ball, CEO of Shoulder Innovations. "This noteworthy expansion of our IP position represents the culmination of over 10 years of research and development, and we are proud of our team for their continued dedication to creating practical solutions for shoulder surgeons and advancing patient outcomes."

Radical Catheter Technologies Presents Analysis of Disruptive, Recently FDA-Cleared Endovascular Technology at the Society of NeuroInterventional Surgery 21st Annual Meeting

This new catheter, the first product commercialized from this novel technology platform, is designed to enable access to the blood vessels in the brain for both femoral and radial access. A multi-center analysis of this disruptive technology is being presented today at Society of NeuroInterventional Surgery 21st annual meeting. In addition, the Company confirmed the closing of a $20 million financing round led by NeuroTechnology Investors, which will be used to scale the company and expand the Radical platform notes Radical Catheter Technologies.

Rapid Medical™ Completes Initial Neurovascular Cases in the USA Following FDA Clearance of Its Active Access Solution

“With DRIVEWIRE, our design goal was to bring new levels of access and control to the interventional suite while improving best-in-class guidewires,” comments Giora Kornblau, Chief Technology Officer at Rapid Medical. “When physicians are looking for technologies that increase the clinical possibilities and safety for the patient, we want Rapid to be the first place they look.”